Biopharmaceutical applications of α-galactosidases

被引:4
作者
Anisha, Grace Sathyanesan [1 ]
机构
[1] Govt Coll Women, Postgrad & Res Dept Zool, Thiruvananthapuram, Kerala, India
关键词
blood group conversion; Fabry's disease; flatulence; xenotransplantation; alpha-galactosidase; BROAD SUBSTRATE-SPECIFICITY; ENZYME REPLACEMENT THERAPY; GOOD HYDROLYTIC ACTIVITY; RED-BLOOD-CELLS; GROUP-B; FABRY-DISEASE; N-ACETYLGALACTOSAMINIDASE; PHARMACOLOGICAL CHAPERONE; DOUBLE-BLIND; RESISTANT;
D O I
10.1002/bab.2349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Galactosidases are exoglycosidases that are active on galactose-containing side chains in oligosaccharides, polysaccharides, glycolipids, and glycoproteins. alpha-Galactosidases are gaining increased interest in human medicine, especially in the enzyme replacement therapy for Fabry's disease. alpha-Galactosidases with regioselectivity toward alpha-1,3-linked galactose find application in xenotransplantation and blood group transformation. The use of alpha-galactosidases as a therapeutic agent in alleviating the postprandial symptoms of irritable bowel syndrome is much acclaimed. The excellent therapeutic applications of alpha-galactosidases have led to an upwelling of worldwide research interventions to identify novel alpha-galactosidases with improved catalytic efficiency. In addition to these therapeutic applications, alpha-galactosidases also have interesting applications in the industrial sectors like food, feed, probiotics, sugar, and paper pulp. The current review focuses on the diverse therapeutic applications of alpha-galactosidases and their prospects.
引用
收藏
页码:257 / 267
页数:11
相关论文
共 74 条
  • [1] Optimization of Saccharomyces cerevisiae α-galactosidase production and application in the degradation of raffinose family oligosaccharides
    Alvarez-Cao, Maria-Efigenia
    Cerdan, Maria-Esperanza
    Gonzalez-Siso, Maria-Isabel
    Becerra, Manuel
    [J]. MICROBIAL CELL FACTORIES, 2019, 18 (01)
  • [2] Microbial α-galactosidases: Efficient biocatalysts for bioprocess technology
    Anisha, Grace Sathyanesan
    [J]. BIORESOURCE TECHNOLOGY, 2022, 344
  • [3] Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors
    Arends, Maarten
    Biegstraaten, Marieke
    Hughes, Derralynn A.
    Mehta, Atul
    Elliott, Perry M.
    Oder, Daniel
    Watkinson, Oliver T.
    Vaz, Frederic M.
    van Kuilenburg, Andre A. B. P.
    Wanner, Christoph
    Hollak, Carla E. M.
    [J]. PLOS ONE, 2017, 12 (08):
  • [4] Bakunina IY, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1209
  • [5] Molecular Characterization and Therapeutic Potential of a Marine Bacterium Pseudoalteromonas sp KMM 701 α-Galactosidase
    Balabanova, Larissa A.
    Bakunina, Irina Yu.
    Nedashkovskaya, Olga I.
    Makarenkova, Ilona D.
    Zaporozhets, Tatiana S.
    Besednova, Natalia N.
    Zvyagintseva, Tatiana N.
    Rasskazov, Valery A.
    [J]. MARINE BIOTECHNOLOGY, 2010, 12 (01) : 111 - 120
  • [6] Microbial production and biotechnological applications of α-galactosidase
    Bhatia, Sonu
    Singh, Abhinashi
    Batra, Navneet
    Singh, Jagtar
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 150 : 1294 - 1313
  • [7] Systemic Treatment of Fabry Disease Using a Novel AAV9 Vector Expressing α-Galactosidase A
    Biferi, Maria Grazia
    Cohen-Tannoudji, Mathilde
    Garcia-Silva, Andrea
    Souto-Rodriguez, Olga
    Vieitez-Gonzalez, Irene
    San-Millan-Tejado, Beatriz
    Fernandez-Carrera, Andrea
    Perez-Marquez, Tania
    Teijeira-Bautista, Susana
    Barrera, Soraya
    Dominguez, Vanesa
    Marais, Thibaut
    Gonzalez-Fernandez, Africa
    Barkats, Martine
    Ortolano, Saida
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 1 - 17
  • [8] A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients
    Bohn, Lena
    Tornblom, Hans
    Van Oudenhove, Lukas
    Simren, Magnus
    Storsrud, Stine
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (07)
  • [9] Chauhan Aishwarya Singh, 2015, Biotechnol Res Int, V2015, P860343, DOI 10.1155/2015/860343
  • [10] Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency
    Cheng, Wei-Chieh
    Wang, Jen-Hon
    Li, Huang-Yi
    Lu, Sheng-Jhih
    Hu, Jia-Ming
    Yun, Wen-Yi
    Chiu, Cheng-Hsin
    Yang, Wen-Bin
    Chien, Yin-Hsiu
    Hwu, Wuh-Liang
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 : 14 - 20